Clearside Biomedical Inc (CLSD)
1.02
-0.03
(-2.86%)
USD |
NASDAQ |
Nov 21, 16:00
1.02
0.00 (0.00%)
Pre-Market: 08:04
Clearside Biomedical Total Liabilities (Quarterly): 63.95M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 63.95M |
| June 30, 2024 | 62.22M |
| March 31, 2024 | 61.95M |
| December 31, 2023 | 49.93M |
| September 30, 2023 | 47.27M |
| June 30, 2023 | 44.16M |
| March 31, 2023 | 42.00M |
| December 31, 2022 | 40.70M |
| September 30, 2022 | 37.14M |
| June 30, 2022 | 5.498M |
| March 31, 2022 | 4.356M |
| December 31, 2021 | 4.928M |
| September 30, 2021 | 9.53M |
| June 30, 2021 | 9.254M |
| March 31, 2021 | 10.84M |
| December 31, 2020 | 10.56M |
| September 30, 2020 | 9.281M |
| June 30, 2020 | 10.45M |
| March 31, 2020 | 14.60M |
| Date | Value |
|---|---|
| December 31, 2019 | 15.62M |
| September 30, 2019 | 16.11M |
| June 30, 2019 | 16.95M |
| March 31, 2019 | 21.44M |
| December 31, 2018 | 20.50M |
| September 30, 2018 | 25.30M |
| June 30, 2018 | 21.34M |
| March 31, 2018 | 18.53M |
| December 31, 2017 | 19.08M |
| September 30, 2017 | 17.98M |
| June 30, 2017 | 14.09M |
| March 31, 2017 | 14.80M |
| December 31, 2016 | 13.15M |
| September 30, 2016 | 10.83M |
| June 30, 2016 | 10.27M |
| March 31, 2016 | 11.45M |
| December 31, 2015 | 57.71M |
| September 30, 2015 | 8.848M |
| December 31, 2014 | 29.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.356M
Minimum
Mar 2022
63.95M
Maximum
Sep 2024
27.71M
Average
15.11M
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 62.68M |
| Viking Therapeutics Inc | 26.44M |
| Atara Biotherapeutics Inc | 233.24M |
| Corvus Pharmaceuticals Inc | 46.41M |
| Crinetics Pharmaceuticals Inc | 104.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.16M |
| Shareholders Equity (Quarterly) | -34.79M |
| Current Ratio | 4.490 |